Global Renal Denervation Market 2016-2020

  • ID: 3802207
  • Report
  • Region: Global
  • 47 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Boston Scientific
  • Cardiosonic
  • Cordis
  • Kona Medical
  • Medtronic
  • ReCor Medical
  • MORE
About Renal Denervation

Renal denervation is a catheter-based minimally-invasive ablation procedure that helps reduce systolic blood pressure in individuals with drug-resistant hypertension. Systolic blood pressure is the first recorded reading. Diastolic blood pressure measures the pressure in the blood vessels when the heart rests between beats. The renal denervation catheter is introduced through the femoral artery in the upper thigh. The physician then makes several lesions using radiofrequency or ultrasound along the sympathetic nerves. These nerves connect the brain, heart, blood vessels, and kidneys, and play a major role in the management of hypertension.

The analysts forecast the global renal denervation market to grow at a CAGR of 11.82% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global renal denervation market for 2016-2020. To calculate the market size, the analyst considers the revenue generated from the sales of renal denervation devices as the demand for these devices is high.

The market is divided into the following segments based on geography:
- Europe
- ROW

The report, Global Renal Denervation Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Boston Scientific
- Medtronic
- ReCor Medical
- St. Jude Medical

Other prominent vendors
- Cardiosonic
- Cordis (a subsidiary of Johnson & Johnson)
- Kona Medical
- Sound Intervention
- Terumo

Market drivers
- Widespread prevalence of hypertension
- For a full, detailed list, view the full report

Market challenges
- Negative results of clinical studies
- For a full, detailed list, view the full report

Market trends
- Funding for development of therapies
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Boston Scientific
  • Cardiosonic
  • Cordis
  • Kona Medical
  • Medtronic
  • ReCor Medical
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Impact of SYMPLICITY on global renal denervation market
  • Medtronic's SYMPLICITY clinical trial
PART 06: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 07: Geographical segmentation
  • Renal denervation market in Europe
  • Renal denervation market in ROW
PART 08: Market drivers
  • Widespread prevalence of hypertension
  • Use of minimally-invasive procedures
  • Technological innovations to simplify renal denervation
PART 09: Impact of drivers

PART 10: Market challenges
  • Negative results of clinical studies
  • Alternative treatment options
  • High cost of renal denervation
PART 11: Impact of drivers and challenges

PART 12: Market trends
  • Funding for development of therapies
  • Increase in M&A
  • Use of radiofrequency technology
PART 13: Vendor landscape
  • Competitive scenario
  • Boston Scientific
  • Medtronic
  • ReCor Medical
  • St. Jude Medical
  • Other prominent vendors
PART 14: Appendix
  • List of abbreviations
PART 15: About the Author

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Studies conducted on SYMPLICITY devices
Exhibit 03: Global renal denervation market 2015-2020 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global renal denervation market by geography 2015
Exhibit 06: Estimated market opportunity of renal denervation devices in Europe 2015-2020
Exhibit 07: Renal denervation market in Europe 2015-2020 ($ millions)
Exhibit 08: Estimated market opportunity of renal denervation devices in US 2015-2020
Exhibit 09: Estimated market opportunity of renal denervation devices in Japan 2015-2020
Exhibit 10: Renal denervation market in ROW 2015-2020 ($ millions)
Exhibit 11: Global renal denervation market segmentation by geography 2015-2020
Exhibit 12: Impact of drivers
Exhibit 13: Impact of drivers and challenges
Exhibit 14: Boston Scientific: Key takeaways
Exhibit 15: Medtronic: Key takeaways
Exhibit 16: ReCor Medical: Key takeaways
Exhibit 17: St. Jude Medical: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Boston Scientific
  • Cardiosonic
  • Cordis
  • Kona Medical
  • Medtronic
  • ReCor Medical
  • MORE
New Report Released: – Global Renal Denervation Market 2016-2020

The author of the report recognizes the following companies as the key players in the global renal denervation market: Boston Scientific, Medtronic, ReCor Medical, and St. Jude Medical.

Other Prominent Vendors in the market are: Cardiosonic, Cordis, Kona Medical, Sound Intervention, and Terumo.

Commenting on the report, an analyst from the research team said: “Increase in M&A will be a key trend for market growth. Vendors present in the market are undergoing M&A to expand their global presence, mitigate the loss of patent protection, expand their product portfolio, and achieve economies of scale. For instance, Boston Scientific acquired Vessix Vascular, a developer of catheter-based renal denervation systems for treating uncontrolled hypertension, in January 2012. Boston Scientific expects that the Vessix Vascular renal denervation system will help it gain market leadership. These types of M&A will provide substantial synergies for many vendors, including an enviable combination to access a global customer base, as well as complement expansion of product portfolios.”

According to the report, widespread prevalence of hypertension will be a key driver for market growth. Unhealthy diet, stress, and physical inactivity can lead to conditions such as hypertension, hypercholesterolemia, coronary artery disease, and diabetes. Hypertension or high blood pressure can cause ischemia and stroke. With each passing year, the prevalence of hypertension is rising worldwide. In 2013, CDC estimated that more than 30% of the global adult population had hypertension.

Further, the report states that alternative treatment options will be a major challenge for the market. Renal denervation devices are technologically advanced, are safe to use, and offer a one-time solution for the management of hypertension. However, many people worldwide still opt for drug therapy for treating hypertension. Physicians prescribe beta blockers, thiazide diuretics, calcium-channel blockers, and renal inhibitors for treating people with hypertension. In addition, non-pharmacological therapies, such as weight loss, exercising in moderation, and dietary salt restriction can help reduce high blood pressure levels.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Boston Scientific
- Medtronic
- ReCor Medical
- St Jude Medical
- Cardiosonic
- Cordis
- Kona Medical
- Sound Intervention
- Terumo
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll